Long-term oral bosentan treatment in patients with pulmonary arterial hypertension related to congenital heart disease: a 2-year study.
about
Pulmonary arterial hypertension associated with congenital heart disease and Eisenmenger syndrome: current practice in pediatricsCanadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: complex congenital cardiac lesions.Adult patients with pulmonary arterial hypertension due to congenital heart disease: a review on advanced medical treatment with bosentanExercise testing and prescription in patients with congenital heart disease.Advanced pulmonary vascular disease: the Eisenmenger syndrome.Pharmacoeconomic evidence of bosentan for pulmonary arterial hypertension.The challenge of managing pulmonary arterial hypertension in adults with congenital heart disease.Pulmonary hypertension related to congenital heart disease: a call for action.Current topics in surgery for isolated total anomalous pulmonary venous connection.Common long-term complications of adult congenital heart disease: avoid falling in a H.E.A.P.The Adult Patient with Eisenmenger Syndrome: A Medical Update after Dana Point Part II: Medical Treatment - Study Results.Bosentan in pulmonary arterial hypertension: a comparison between congenital heart disease and chronic pulmonary embolism.Sildenafil add-on therapy in paediatric pulmonary arterial hypertension, experiences of a national referral centre.Duration of right ventricular contraction predicts the efficacy of bosentan treatment in patients with pulmonary hypertension.Advanced therapies for the management of adults with pulmonary arterial hypertension due to congenital heart disease: a systematic review.Adult congenital heart disease and pulmonary arterial hypertension: the Texas Adult Congenital Heart Program experience.The efficiency of endothelin receptor antagonist bosentan for pulmonary arterial hypertension associated with congenital heart disease: A systematic review and meta-analysis.
P2860
Q28085572-62D246B6-A127-4F8B-9D9D-14171C82CBF1Q33776432-C3B0C8A1-CE28-4A68-B33F-3C6F1065B5B1Q34133301-B664CB70-AA5F-424E-8356-FC495998F841Q34143576-CEA5C5A7-B4EC-4C03-BFBB-E71ABB652A63Q37613797-7B5481C4-F030-4F82-B747-F22C597AF366Q37889264-76C6EB44-1DEC-47D0-8518-C8DFB85591AFQ38124878-E58C61EF-9C7C-4FE6-94AC-308B18D7DC35Q38156253-CA35AF0D-01C5-4B9C-9E41-CC853B487B3BQ38196359-DC241536-7D94-4917-A798-C017BE175F12Q38672312-28E7EDBD-BE60-4C43-869B-1A1D5D016E49Q41852030-1887DAAB-08A3-44E3-847A-D556F798D8D0Q42284467-1FEDEFCA-2B97-4A05-8670-E22B310A1D36Q43680261-2F870B80-3689-45F2-8423-B7D5E8927135Q46222874-0620F75A-C3AF-4CDF-87C5-45F93B941D19Q47561539-6B37BDC2-A770-45E8-90E8-3211640417B0Q51493465-EB812E0A-FA16-409E-99A0-212AD18CC6E3Q53703751-CDE0EC9F-448F-4A88-B7D2-1E340D292CB7
P2860
Long-term oral bosentan treatment in patients with pulmonary arterial hypertension related to congenital heart disease: a 2-year study.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Long-term oral bosentan treatm ...... heart disease: a 2-year study.
@ast
Long-term oral bosentan treatm ...... heart disease: a 2-year study.
@en
type
label
Long-term oral bosentan treatm ...... heart disease: a 2-year study.
@ast
Long-term oral bosentan treatm ...... heart disease: a 2-year study.
@en
prefLabel
Long-term oral bosentan treatm ...... heart disease: a 2-year study.
@ast
Long-term oral bosentan treatm ...... heart disease: a 2-year study.
@en
P2093
P2860
P356
P1433
P1476
Long-term oral bosentan treatm ...... heart disease: a 2-year study.
@en
P2093
A Manginas
D V Cokkinos
S C Apostolopoulou
P2860
P304
P356
10.1136/HRT.2006.100388
P407
P577
2006-09-15T00:00:00Z